Ethereum

Rally

Injective

Gains

As utility-driven altcoin start to gain prominence, the crypto market is seeing a change. Ethereum struggles to maintain momentum, but Injective (INJ) and IntelMarkets (INTL) are leading the charge with double-digit gains to boot. 
<h2 id="strong-intelmarkets-intl-redefining-crypto-trading-strong">IntelMarkets (INTL): Redefining Crypto Trading</h2> 
<a href="https://intelmarketspresale.com?utm_source=Timestabloid&amp;utm_medium=teo&amp;utm_campaign=01" rel="nofollow">IntelMarkets (INTL)</a> has become one of the most appealing cryptocurrencies in the market due to its distinctive AI, blockchain and DeFi functionality. While Ethereum’s growth could be restricted by the current market environment, IntelMarkets is aiming to change the way crypto trading is done. 
Having increased over 20% from its previous price, INTL tokens are trading at $0.054 at the sixth presale stage. IntelMarkets has pumped over $2.4 million from early backers, making in its solid investor confidence. Being in the news for its limited time bonus offer, where investors who use the promo code INTL20 will get a 20% bonus on their deposit. 
AI is embedded at every level of the project’s trading platform, offering users access to advanced AI based, self learning trading robots. These read real-time market data and execute trades over different asset pairs at unbelievable speed. This is a cutting-edge approach that makes IntelMarkets the best retail trading platform for realizing gains when trading crypto. 
<h2 id="strong-injective-inj-sustained-momentum-in-a-competitive-market-strong">Injective (INJ): Sustained Momentum in a Competitive Market</h2> 
Looking at the DeFi sector, there is an Ethereum based solution, Injective (INJ), which is a special case in the decentralized finance sector. Injective is the first protocol to allow for auto-executing smart contracts. This allows for the deployment of faster and more innovative applications. 
Currently INJ trades at $29.52, up from $16.17 when Injective hit near the 30 day low. Its upward trajectory reflects increasing adoption and the Injective ecosystem. Over the past year, Injective has shown resilience, never falling below the $14 support. 
While INJ growth is consistent some analysts claim it has a limited upside compared to up and coming projects like IntelMarkets. As Injective is an established player with a huge market cap of $3 billion, some investors believe that INJ’s potential is capped. 
<h2 id="strong-ethereum-eth-the-giant-proving-resilient-strong">Ethereum (ETH): The Giant Proving Resilient</h2> 
Ethereum (ETH) is still a foundation of a large portion of the crypto ecosystem with its pioneering smart contract capabilities. ETH is currently trading at $3,560, down from its 30-day high of $3,685. Noting a 30% increase from the previous month, ETH has proven to be one of the most solid gainers this cycle. 
Some critics claim that Ethereum has scaling issues in the long run, and high transaction costs have also dampened its performance in comparison with other Layer-1s, such as Solana and Injective. They elaborate that Ethereum’s growth is limited due to its sky-high market cap. In comparison, smaller, high-growth projects have far more upside potential than ETH. However, some predictions place an Ethereum rally to $5,000 in the next bull market, which is highly possible. 
<h2 id="strong-conclusion-strong">Conclusion</h2> 
While Injective (INJ) continues to be a gradual gainer and a strong competitor to Ethereum (ETH), savvy investors point out that, similar to Ethereum, its room for growth is limited due to its $2.8B market cap. 
For some investors IntelMarkets (INTL) is a breath of fresh air. With its revolutionary AI driven trading platform, low presale price and high growth potential, it’s definitely a top presale pick this December. 
Learn More About IntelMarkets: 
<a href="https://intelmarketspresale.com?utm_source=Timestabloid&amp;utm_medium=teo&amp;utm_campaign=01" rel="nofollow">Buy Presale</a> 
<a href="https://intelmarketspresale.com?utm_source=Timestabloid&amp;utm_medium=teo&amp;utm_campaign=01" rel="nofollow">Website</a> 
<a href="https://t.me/IntelMarketsOfficial" rel="nofollow">Telegram</a> 
Disclaimer:&nbsp;This is a sponsored press release for informational purposes only. It does not reflect the views of Times Tabloid, nor is it intended to be used as legal, tax, investment, or financial advice. Times Tabloid is not responsible for any financial losses. 
The post <a href="https://timestabloid.com/intelmarkets-and-injective-lead-utility-altcoins-rally-with-double/">IntelMarkets and Injective Lead Utility Altcoins Rally With Double Digit Gains Despite Ethereum Price Slump</a> appeared first on <a href="https://timestabloid.com">Times Tabloid</a>.

IntelMarkets and Injective Lead Utility Altcoins Rally With Double Digit Gains Despite Ethereum Price Slump

Table of Contents

Times Tabloid

Other articles published on Nov 29, 2024

SOL, XRP set to explode into 2025 but this altcoin could outshine both

Big Claim: Ripple (XRP) Case Nears End, SEC May Withdraw Objection!

Top Altcoins With 100x Potential To Stack Now

Best Meme Coins to Buy for December 2024: BTFD Coin Heats Up the Market, Turbo Surges, and Book o...

Will XRP Hit $3 Before Christmas? Whales Think So

Trump’s Team Discusses Potential White House Crypto Role Amid Growing Industry Influence

Join our free newsletter for daily crypto updates!